Composition useful as a dietary supplement

1. A combination composition comprising as active ingredients: L-carnitine or a salt thereof in a dose of from 2589 to 287.6 mg (corresponding to 1500-166.6 mg L-carnitine inner salt), acetyl L-carnitine or a salt thereof in a dose of from 750 to 25.0 mg, vitamin B9 (folic Acid) in a dose of from 600 to 66.6 μg, vitamin A in a dose of from 2400 to 266.6 μg, vitamin B12 in a dose of from 7.5 to 0.833 μg, vitamin B5 (pantothenic acid) in a dose of from 18.0 to 2.0 mg, vitamin B6 (pyridoxine) in a dose of from 6.0 to 0.666 mg, arginine in a dose of from 1500 to 166.6 mg, vitamin C in a dose of from 270.0 to 30.0 mg, vitamin E (α-Tocopherol) in a dose of from 90.0 to 10.0 mg, selenium in a dose of from 150 to 16.6 μg, zinc in a dose of from 30.0 to 3.33 mg, copper in a dose of from 4.95 to 0.55 mg, iron in a dose of from 42.0 to 4.66 mg, vitamin D in a dose of from 15.0 to 1.66 μg and N-acetyl cysteine in a dose of from 150 to 16.6 mg, and optionally one or more pharmaceutically acceptable excipients.

2. The combination composition of claim 1 , further comprising co-enzymes, mineral substances, antioxidants, and vitamins.

3. A dietary supplement comprising the combination composition of claim 1 .

4. The combination composition of claim 1 , in which the salt of L-carnitine or acetyl L-carnitine is selected from the group consisting of chloride, bromide, orotate, aspartate, citrate, phosphate, fumarate, lactate, maleate, oxalate, pamoate, sulphate, tartrate and mucate.

5. The combination composition of claim 1 , for oral administration.

6. The combination composition of claim 1 , which comprises:

L-carnitine fumarate in a dose of from 1726 to 431.5 mg (corresponding to 1000-250 mg of L-carnitine inner salt);

Acetyl L-carnitine in a dose of from 500 to 125 mg;

folic acid (vitamin B9) in a dose of from 400 to 100 μg;

vitamin A from beta carotene in a dose of from 1600 to 400 μg;

vitamin B12 in a dose of from 5.0 to 1.250 μg;

vitamin B5 (pantothenic) in a dose of from 12.0 to 3.0 mg;

vitamin B6 (pyridoxine) in a dose of from 4.0 to 1.0 mg;

arginine in a dose of from 1000.0 to 250.0 mg;

vitamin C in a dose of from 180.0 to 45.0 mg;

vitamin E (α-Tocopherol) in a dose of from 60.0 to 15.0 mg;

selenium in a dose of from 100.0 to 25.0 μg;

zinc in a dose of from 20.0 to 5.0 mg;

copper in a dose of from 3.3 to 0.825 mg;

iron in a dose of from 28.0 to 7.0 mg;

vitamin D in a dose of from 10.00 to 2.50 μg; and

N-acetyl cysteine in a dose of from 100.0 to 25.0 mg.

7. The combination composition of claim 6 , which comprises:

L-carnitine fumarate in a dose of 863 mg (corresponding to 500 mg of L-carnitine inner salt);

Acetyl L-carnitine in a dose of 250 mg;

folic acid (vitamin B9) in a dose of 200 μg;

vitamin A from beta carotene in a dose of 800 μg;

vitamin B12 in a dose of 2.5 μg;

vitamin B5 (pantothenic) in a dose of 6 mg;

vitamin B6 (pyridoxine) in a dose of 2 mg;

arginine in a dose of 500 mg;

vitamin C in a dose of 90 mg;

vitamin E (α-Tocopherol) in a dose of 30 mg;

selenium in a dose of 50 μg;

zinc in a dose of 10 mg;

copper in a dose of 1.65 mg;

iron in a dose of 14 mg;

vitamin D in a dose of 5 μg; and

N-acetyl cysteine in a dose of 50 mg.

8. A method of promoting female fertility, the method comprising administering the combination composition of claim 1 to a women in need thereof.

9. A method of promoting female fertility during drug stimulation, hormonal stimulation, or drug and hormonal stimulation, the method comprising administering the combination composition of claim 1 to a women in need thereof.

10. A method of promoting female fertility during drug stimulation, hormonal stimulation, or drug and hormonal stimulation for supporting ovulation, the method comprising administering the combination composition of claim 1 to a women in need thereof.

11. The method of claim 10 , in which the administration of the combination composition is started at least a month before the beginning of the drug stimulation, hormonal stimulation, or drug and hormonal stimulation.

12. The method of claim 10 in which the administration of the combination composition is started at least a week before the beginning of the drug stimulation, hormonal stimulation, or drug and hormonal stimulation.

13. A method of promoting female fertility during during drug stimulation, hormonal stimulation, or drug and hormonal stimulation for promoting oocyte fertilization, the method comprising administering the combination composition of claim 1 to a women in need thereof.

14. A method of promoting female fertility during drug stimulation, hormonal stimulation, or drug and hormonal stimulation for promoting oocyte fertilization in vivo, the method comprising administering the combination composition of claim 1 to a women in need thereof.

15. A method of promoting female fertility during drug stimulation, hormonal stimulation, or drug and hormonal stimulation for promoting oocyte fertilization in vitro, the method comprising administering the combination composition of claim 1 to a women in need thereof.

16. A method of reducing side effects due to the use of hormones, drugs, or hormone and drugs useful for promoting female fertility, the method comprising administering the combination composition of claim 1 to a women in need thereof.